The present disclosure relates to synthetic Plasmodium
reticulocyte binding protein 2b (mRBP2b) antigens that have improved properties such as
thermal stability, as well as the use of these antigens to detect a Plasmodium infection in a diagnostic device or for use in a vaccine.